Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000772

Drug Information
SynonymsR-Tofisopam; AC1L4BXA; UNII-EZ15I5D6C1; Dextofisopam; D03737; Dextofisopam (USAN/INN); CID204105; 82059-50-5; (5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine
CompanyVela Pharmaceuticals
IndicationIrritable bowel syndrome
[ICD9: 564.1   ICD10: K58]
Phase II    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C    
Isomeric SMILESCC[C@H]1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C
CAS NumberCAS 82059-50-5
PubChem Compound IDCID 204105.
PubChem Substance IDSID 779980.
SuperDrug ATC IDA10BG03
SuperDrug CAS ID111025468;
TargetGABA receptorAgonist[1]
GABA receptorMultitarget[1]
Peripheral-type benzodiazepine receptorAgonist[1]
Peripheral-type benzodiazepine receptorMultitarget[1]
Ref 1Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543